Capital expenditure · 2019–2025

Bioventus capital expenditure

$2.6M+154.7% · FY2025

Bioventus (BVS) reported $2.6M in capital expenditure for fiscal 2025, +154.7% year on year.

$2.3M2019$16.6M2020$13.5M2021$1.5M2022$7.4M2023$1.0M2024$2.6M2025
Bioventus — Capital expenditure, 2019–2025
Fiscal yearCapital expenditureChangeFiling
FY20252025-12-31$2.6M+154.7%Open →
FY20242024-12-31$1.0M−86.3%Open →
FY20232023-12-31$7.4M+398.1%Open →
FY20222022-12-31$1.5M−89.1%Open →
FY20212021-12-31$13.5M−18.5%Open →
FY20202020-12-31$16.6M+607.9%Open →
FY20192019-12-31$2.3M—Open →

Capital expenditure — Capital expenditure is the cash the company spent during the year on property, plant and equipment — factories, stores, servers, vehicles. It appears in the investing section of the cash-flow statement as an outflow and is shown here as a positive amount. Operating cash flow minus this figure is free cash flow.

Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026 · 2019–2025 compound annual growth +1.5%

Capital expenditure at companies of similar size

Cite this page

Ready-made references for the figures on this page, as published on September 25, 2026.

Wikipedia

{{cite web |title=Bioventus capital expenditure |url=https://companiesranked.com/en/company/bioventus/capital-expenditure |website=CompaniesRanked |date=2026-09-25 |language=en}}

APA 7

CompaniesRanked. (September 25, 2026). Bioventus capital expenditure. CompaniesRanked. https://companiesranked.com/en/company/bioventus/capital-expenditure

BibTeX

@misc{companiesranked-en-company-bioventus-capital-expenditure-2026,
  author       = {{CompaniesRanked}},
  title        = {{Bioventus capital expenditure}},
  year         = {2026},
  howpublished = {\url{https://companiesranked.com/en/company/bioventus/capital-expenditure}},
  note         = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
  urldate      = {2026-09-25}
}

The filing itself

The numbers above are read from this document: 10-K · 0001665988-26-000011 · March 5, 2026

{{cite web |title=Bioventus capital expenditure — 10-K (0001665988-26-000011) |url=https://www.sec.gov/Archives/edgar/data/1665988/000166598826000011/bvs-20251231.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-03-05}}

The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.

← Bioventus overview